Stock market exuberance is here to stay, Credit Suisse says. Here’s why investors can be positive

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 78 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

“Bullish sentiment is high but at these levels markets continue to rise two-thirds of the time over the next month and we think the bullish sentiment is not reflected in retail or institutional position.'

After a volatile first week of 2021, the second week of the year has started in a slightly calmer fashion.

However, in our call of the day, Credit Suisse strategists said the exuberance was likely to continue, raising their target for global stocks and the S&P 500 SPX, -0.49%. The investment bank’s analysts, led by Andrew Garthwaite, raised their end-year MSCI World Ex-U.S. target from 362 to 375, giving a 12.3% potential return from here. They said it was in line with the bank’s U.S. strategists, who raised the year-end S&P 500 target to 4,200.

The strategists’ only worry was that 80% of stocks currently sit above their 200-day moving average, which would typically see markets fall two-thirds of the time over the next month. However, they said: “But in the very early cycle, as we are, this is not a short-term sell signal.Beyond the near term, there were a number of strategic reasons to stay positive, they said, including “ultraloose” policy and an additional U.S. fiscal boost of close to 2% of gross domestic product.

The markets U.S. stocks fell at the open on Monday, after closing at fresh all-time highs on Friday. European stocks also fell, as investors assessed surging COVID-19 cases and tough lockdowns across the continent. Bond yields TMUBMUSD10Y, 1.131% rose on concerns the Federal Reserve will be less interested in maintaining the rate of its purchases of them.

Shares in Eli Lilly LLY, +12.42% jumped more than 12% after the U.S. drugmaker said its experimental Alzheimer’s disease drug helped slow the decline of cognition and daily function in patients with early forms of the disease.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines